Breaking News

Transposagen, Taconic Enter Distribution Pact

Transposagen Biopharmaceuticals, a provider of genetically modified laboratory rats, has entered into a global marketing and distribution agreement with Taconic, an animal model and service provider, in which Taconic will market and distribute Transposage

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Transposagen Biopharmaceuticals, a provider of genetically modified laboratory rats, has entered into a global marketing and distribution agreement with Taconic, an animal model and service provider, in which Taconic will market and distribute Transposagen’s animal models. Transposagen has exclusive worldwide rights to create TKO Knockout Rat Models using a variety of mobile DNA technologies. Knockout rat research models have a single gene disruption that mimics human diseases. There are curr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters